A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus

Conditions: Congenital Cytomegalovirus Infection Interventions: Drug: Letermovir Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials